Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 versus beclomethasone in adolescents with moderate to severe persistent asthma
2007-000522-46Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclometasone dipropionate + formoterol and beclomethasone dipropionate in asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Change from baseline in pre-dose morning peak expiratory flow. Started May 2007; status: completed.
02
Drugs
beclometasone dipropionate + formoterolbeclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-000522-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000522-46.